Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan

Table 4 Comparison of mean scores of Short Form 36 (SF-36) Health-related Quality of Life (HRQOL) Questionnaire in 21 sustained virological responders at different time points of antiviral treatment¹

SF-36 domains/stages	Before treatment	At 12th wkof treatment	At the end of Treatment	At the 6th moafter stopping treatment
General health	58.9±19.1	59.1±19.5	67.9±11.5a	86.9±12.9b
Physical functioning	74.0±20.3	71.9±19.0	76.0±17.4	83.9±3.6a
Role-physical	78.6±39.8	77.4±40.2	91.7±24.1	100.0±0a
Role-emotional	76.2±39.6	74.6±43.3	87.3±30.7	98.2±7.6a
Social functioning	78.1±13.4	67.5±12.4a	72.0±11.8	89.9±10.9b
Body pain	75.9±17.6	67.4±21.3	77.1±15.3	94.1±10.9b
Vitality	61.7±17.4	60.0±14.0	63.1±16.0	81.0±8.5b
Mental health	70.7±17.2	65.7±11.0	67.0±16.0	82.9±6.7b

¹By paired t- test;

^aP<0.05;

^bP<0.01.